Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.008 AUD 14.29% Market Closed
Market Cap: 8.7m AUD

Intrinsic Value

The intrinsic value of one PER stock under the Base Case scenario is 0.002 AUD. Compared to the current market price of 0.008 AUD, Percheron Therapeutics Ltd is Overvalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PER Intrinsic Value
0.002 AUD
Overvaluation 75%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Percheron Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about PER?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PER valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Percheron Therapeutics Ltd.

Explain Valuation
Compare PER to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PER?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Percheron Therapeutics Ltd

Current Assets 12.4m
Cash & Short-Term Investments 10.2m
Receivables 1.6m
Other Current Assets 650.4k
Non-Current Assets 35.3k
PP&E 35.3k
Efficiency

Free Cash Flow Analysis
Percheron Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Percheron Therapeutics Ltd

Revenue
371.1k AUD
Operating Expenses
-16.7m AUD
Operating Income
-16.3m AUD
Other Expenses
1.4m AUD
Net Income
-14.9m AUD
Fundamental Scores

PER Profitability Score
Profitability Due Diligence

Percheron Therapeutics Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

46/100
Profitability
Score

Percheron Therapeutics Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

PER Solvency Score
Solvency Due Diligence

Percheron Therapeutics Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Percheron Therapeutics Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PER Price Targets Summary
Percheron Therapeutics Ltd

There are no price targets for PER.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Percheron Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PER is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PER stock?

The intrinsic value of one PER stock under the Base Case scenario is 0.002 AUD.

Is PER stock undervalued or overvalued?

Compared to the current market price of 0.008 AUD, Percheron Therapeutics Ltd is Overvalued by 75%.

Back to Top